Guselkumab Leads to Rapid Ulcerative Colitis Symptom Improvement

Induction treatment with guselkumab resulted in a rapid onset of efficacy, beginning at week 1 and increasing over time to week 12, for patients with refractory moderately to severely active ulcerative colitis.

Related Keywords

Vancouver ,British Columbia ,Canada ,Liechtenstein ,Lichtenstein , ,American College Of Gastroenterology ,University Of Pennsylvania Gary Lichtenstein ,Gary Lichtenstein ,American College ,Scientific Meeting ,Severely Active Ulcerative Colitis ,Guselkumab ,Ulcerative Colitis ,Symptom ,